Compare Quantum Computing Inc (QUBT) vs ResMed Inc. (RMD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Quantum Computing Inc vs ResMed Inc. — how do they compare? Quantum Computing Inc trades at $7.95 (market cap $1.85B), while ResMed Inc. trades at $194 (market cap $28.40B). The key difference: ResMed Inc. is far larger — about 15.4× Quantum Computing Inc's market cap, and ResMed Inc. pays a 1.23% dividend while Quantum Computing Inc pays none. Which is the better fit depends on your goals.
| QUBT | RMD | |
|---|---|---|
Market Cap | $1.85B | $28.40B |
Sector | Technology | Health |
52-Week High | $24.62 | $293.73 |
52-Week Low | $6.31 | $182.82 |
Enterprise Value | $871.49M | $27.58B |
Dividend Yield | — | 1.23% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Quantum Computing Inc
Quantum Computing Inc. is a company focused on providing accessible quantum computing and quantum-enhanced software solutions for complex problems. The company's technology is designed to run on both classical and quantum hardware, enabling businesses to explore the power of quantum computing today for applications in finance, drug discovery, and logistics. QUBT offers a platform that makes quantum algorithms and software available through the cloud, aiming to democratize access to this advanced computing paradigm.
Read more on QUBT →About ResMed Inc.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →
